84 related articles for article (PubMed ID: 6539221)
1. Non-specific cellular immunity in type I and type II diabetes.
Fövenyi J; Tótpál K; Thaisz E; Garam T
Exp Clin Endocrinol; 1984 Apr; 83(2):203-6. PubMed ID: 6539221
[TBL] [Abstract][Full Text] [Related]
2. [Cellular immunity in diabetes mellitus].
Barañao RI; Rumi LS
Rev Clin Esp; 1984 Jul 15-31; 174(1-2):7-11. PubMed ID: 6083584
[No Abstract] [Full Text] [Related]
3. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
[TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk.
Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D
Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366
[TBL] [Abstract][Full Text] [Related]
5. [Antibody-mediated cytotoxic activity off circulating lymphocytes directed against human red blood cells in type I and type II diabetes].
Fövényi J; Garam T; Tótpál K; Thaisz E; Bakács T
Orv Hetil; 1983 Jun; 124(26):1547-9. PubMed ID: 6604250
[No Abstract] [Full Text] [Related]
6. T-lymphocyte subsets and their cytotoxic capacity in patients with type I and type II diabetes mellitus.
Horváth M; Varsányi M; Jovanovich N; Rózsás Z; Balázsi I
Allergol Immunopathol (Madr); 1986; 14(5):399-405. PubMed ID: 3492131
[TBL] [Abstract][Full Text] [Related]
7. Similar alterations of lymphocyte subpopulations in type I and type II diabetes.
Spooren PF; Vermes I; Soons JW
Neth J Med; 1993 Jun; 42(5-6):163-7. PubMed ID: 8377873
[TBL] [Abstract][Full Text] [Related]
8. [The functional activity and count of the natural killer cells in patients with recently diagnosed diabetes mellitus types I and II].
Salozhin KV; Sura VV; Nasonov EL; Korneeva MN; Smirnova OI
Ter Arkh; 1989; 61(10):104-6. PubMed ID: 2609254
[TBL] [Abstract][Full Text] [Related]
9. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with non-Hodgkin's lymphoma.
Metha BA; Advani SH; Nadkarni SJ
Neoplasma; 1988; 35(1):61-8. PubMed ID: 3352838
[TBL] [Abstract][Full Text] [Related]
10. Not only quantitative but also qualitative changes of serum immunoglobulins in diabetes mellitus.
Cheţa D; Manciulea M; Sântu E; Georgescu M; Perciun R; Sulica A; Mincu I
Rom J Intern Med; 1991; 29(3-4):181-7. PubMed ID: 1784947
[TBL] [Abstract][Full Text] [Related]
11. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell and islet killer cell activities in human type 1 diabetes.
Negishi K; Waldeck N; Chandy G; Buckingham B; Kershnar A; Fisher L; Gupta S; Charles AM
Exp Clin Endocrinol; 1987 Aug; 89(3):345-53. PubMed ID: 3311777
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
14. Cellular immune reactions against rat pancreatic islets mediated by antibodies from type I diabetic patients.
Kruschel B; Jahr H; Marx S; Michaelis D
Biomed Biochim Acta; 1984; 43(5):635-9. PubMed ID: 6383367
[TBL] [Abstract][Full Text] [Related]
15. The cellular nature of concanavalin A-stimulated antibody-dependent cell-mediated cytotoxicity.
Connolly JM; Wunderlich JR
J Immunol; 1980 Apr; 124(4):1917-23. PubMed ID: 7365243
[TBL] [Abstract][Full Text] [Related]
16. Decreased phagocytosis and antibody-dependent cellular cytotoxicity (ADCC) in type-1 diabetes.
Sabioncello A; Rabatic S; Kadrnka-Lovrencic M; Oberiter V; Dekaris D
Biomedicine; 1981 Dec; 35(7-8):227-9. PubMed ID: 7346070
[TBL] [Abstract][Full Text] [Related]
17. [Autoimmunity and viral infections in type-I diabetes mellitus].
Helmke K; Weimer R; Willems W; Otten A; Mäser E; Velcovsky HG; Federlin K
Dtsch Med Wochenschr; 1986 Mar; 111(10):369-73. PubMed ID: 3512225
[TBL] [Abstract][Full Text] [Related]
18. [Cellular immunity in insulin-dependent diabetes mellitus (type 1)].
Korfel J; Kinalska I; Rogowski F; Citko A
Pol Tyg Lek; 1990 May 7-14; 45(19-20):373-5. PubMed ID: 2255653
[TBL] [Abstract][Full Text] [Related]
19. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
[TBL] [Abstract][Full Text] [Related]
20. Natural killer-cell-mediated and antibody-dependent cellular cytotoxicity in leprosy.
Chiplunkar SV; Deshmukh MV; Samson PD; Butlin R; Bhatki WS; Chulawalla RG; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):334-41. PubMed ID: 2376683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
